Reuters logo
a year ago
BRIEF-Novartis: Sandoz' biosimilar rituximab regulatory submission accepted by European Medicines Agency
May 24, 2016 / 5:31 AM / a year ago

BRIEF-Novartis: Sandoz' biosimilar rituximab regulatory submission accepted by European Medicines Agency

May 24 (Reuters) - Novartis AG :

* Sandoz' biosimilar rituximab regulatory submission accepted by European Medicines Agency Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below